• About us
• Contact

Advertisement

Organisation › Details

Affiris AG

On the basis of its proprietary patented AFFITOME®-technology, AFFiRiS develops tailor-made therapeutic peptide vaccines against chronic diseases. Currently, there are 3 drug candidates against Alzheimer’s, Parkinson’s and MSA in clinical development. Further vaccine candidates against Lipid Lowering respectively Atherosclerosis, Diabetes, Psoriasis, Allergies, Asthma as well as for Huntington's are in preclinical development. Thus far, AFFiRiS has been able to attract funding of close to € 100m, thereof ca. € 45m from license agreements. AFFiRiS currently employs 77 highly qualified staff at the Vienna Biocenter in Vienna, Austria. *

 

	Start	2003-11-01 renamed before
	Predecessor	Affiris GmbH
	Industry	therapeutic vaccine
	Industry 2	Affitome® technology
	Person	Siegel, Oliver (Affiris 201506– CEO joined 201409 as COO before Rothschild in London + HSBC plc)
	Person 2	Huber, Christoph (CI3 Cluster 201307 Board Member of CI3 e.V.)
	Region	Wien (Vienna)
	Country	Austria
	Street	22 Karl-Farkas-Gasse
	City	1030 Wien
	Tel	+43-1-7981575-300
		Address record changed: 2020-12-02
Basic data	Employees	C: 51 to 100 (2018-03-01)
		* Document for »About Section«:
		Record changed: 2025-03-16

Advertisement

More documents for Affiris AG

• [1] Marinomed Biotech AG. (1/21/22). "Press Release: Marinomed Announces the Appointment of Dr. Cornelia Kutzer as Chief Business Officer". Korneuburg....
• [2] AC Immune S.A.. (7/27/21). "Press Release: AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH". Lausanne....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.